Proportion of isolates with decreased susceptibility or resistance in Korea

Korea: Proportion of isolates with decreased susceptibility or resistance was 0 in 2018. ◆ Volatile

Latest (2018)
0
World rank
13th
of 52 countries
All-time high
47.54
in 2010
All-time low
0
in 2017
Years of data
9
2009–2018

Proportion of isolates with decreased susceptibility or resistance in Korea, 2009–2018

010203040502009201320182009: 29.32010: 47.52011: 252013: 8.32014: 8.82015: 27.52016: 8.22017: 02018: 0

Source: World Health Organization, Global Health Observatory.

Analysis

In 2018, proportion of isolates with decreased susceptibility or resistance in Korea stood at 0. That is the lowest value across all 9 years on record.

The figure is down 100.0% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Korea peaked at 47.54 in 2010 and was at its lowest, 0, in 2017.

That places Korea 13th out of 52 countries with data for 2018, putting it in the top quarter.

Proportion of isolates with decreased susceptibility or resistance in Korea, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP in Korea, 2009 to 2018.
Year Value Change
2009 29.27
2010 47.54 +62.4%
2011 25 -47.4%
2013 8.33 -66.7%
2014 8.75 +5.0%
2015 27.45 +213.7%
2016 8.2 -70.1%
2017 0 -100.0%
2018 0

Averages by decade

DecadeAverage LowestHighest Years
2000s 29.27 29.27 29.27 1
2010s 15.66 0 47.54 8

Countries ranked near Korea

  1. 10 Belgium 0.6 compare
  2. 11 New Zealand 0.1 compare
  3. 12 Australia 0.01 compare
  4. 13 Argentina 0 compare
  5. 13 Croatia 0
  6. 13 Pakistan 0 compare
  7. 13 Ireland 0 compare
  8. 13 Chile 0
  9. 13 Poland 0
  10. 13 Latvia 0
  11. 13 Slovenia 0 compare
  12. 13 Malta 0
  13. 13 Thailand 0 compare
  14. 13 United Kingdom of Great Britain and Northern Ireland 0
  15. 13 Colombia 0
  16. 13 Cyprus 0
  17. 13 Spain 0 compare
  18. 13 United States of America 0 compare
  19. 13 Paraguay 0
  20. 13 Belarus 0
  21. 13 Philippines 0 compare
  22. 13 Slovakia 0
  23. 13 Sweden 0
  24. 13 Greece 0 compare
  25. 13 France 0
  26. 13 Denmark 0
  27. 13 South Africa 0
  28. 13 Norway 0
  29. 13 India 0 compare
  30. 13 Dominican Republic 0
  31. 13 Austria 0 compare
  32. 13 Peru 0 compare
  33. 13 Côte d'Ivoire 0
  34. 13 Germany 0 compare
  35. 13 Hungary 0
  36. 13 Iceland 0
  37. 13 Sri Lanka 0
  38. 13 Italy 0
  39. 13 Panama 0
  40. 13 Portugal 0
  41. 13 Netherlands 0
  42. 13 Estonia 0

See the full ranking of 52 places →

More health data for Korea

All data for Korea →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Korea?
Proportion of isolates with decreased susceptibility or resistance in Korea was 0 in 2018, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Korea?
The highest recorded value was 47.54 in 2010.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Korea?
The lowest recorded value was 0 in 2017.
How does Korea rank for proportion of isolates with decreased susceptibility or resistance?
Korea ranks 13th out of 52 countries with data for 2018.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in Korea?
Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
Where does this Korea data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 9 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Korea. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 12 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/korea-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/korea-rep/">Proportion of isolates with decreased susceptibility or resistance in Korea</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
52 places, 454 data points, 2009–2020
Last refreshed